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The nasopharynx (NP) is a reservoir for microbes
associated with acute respiratory infections (ARIs).
Lung inflammation resulting fromARIs during infancy
is linked to asthma development. We examined the
NP microbiome during the critical first year of life in
a prospective cohort of 234 children, capturing
both the viral and bacterial communities and
documenting all incidents of ARIs. Most infants
were initially colonized with Staphylococcus or
Corynebacterium before stable colonization with
Alloiococcus or Moraxella. Transient incursions of
Streptococcus, Moraxella, or Haemophilus marked
virus-associated ARIs. Our data identify the NP mi-
crobiome as a determinant for infection spread to
the lower airways, severity of accompanying inflam-
matory symptoms, and risk for future asthma
development. Early asymptomatic colonization with
Streptococcus was a strong asthma predictor, and
antibiotic usage disrupted asymptomatic coloniza-
tion patterns. In the absence of effective anti-viral
therapies, targeting pathogenic bacteria within the
NP microbiome could represent a prophylactic
approach to asthma.
INTRODUCTION
The human microbiome is now recognized as playing an impor-
tant role in the etiology and pathogenesis of myriad diseases
(Weinstock, 2012). However, elucidation of these complex roles
requires targeted characterization of microbial communities704 Cell Host & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Ipresent in relevant spatial niche(s) during critical periods of path-
ogenesis. The focus of this study is the respiratory tract, in partic-
ular the nasopharynx (NP), which is an accessible source of
airway microbial communities (Hilty et al., 2010) and serves as
a conduit for pathogens associated with lower respiratory ill-
nesses (LRIs) that are responsible for substantial morbidity and
mortality worldwide.
Of particular interest is asthma, a multi-factorial disease char-
acterized by airway inflammation and associated smoothmuscle
hyperplasia. It is now recognized that the hallmark persistent
wheeze of asthma is consolidated in childhood and, further,
may progress to chronic asthma in adulthood (Holt and Sly,
2012; Sly et al., 2008) and potentially chronic obstructive pulmo-
nary disease (Tai et al., 2014). We and others have previously
shown that development of persistent atopic (allergic) wheeze
in children is linked to the number of virus-associated febrile
and/or wheezy LRIs experienced during infancy (Jackson
et al., 2008; Kusel et al., 2007, 2012; Oddy et al., 2002). The prin-
cipal virus type of current interest is human rhinoviruses (HRVs),
particularly subtype C (HRV-C) (Bochkov and Gern, 2012); how-
ever, respiratory syncytial virus (RSV) is also recognized as a
major cause of infant LRI (Wu and Hartert, 2011). The relative
contributions of these viral pathogens in asthma initiation remain
controversial (Stein and Martinez, 2010). Further complicating
the picture, recent studies have also implicated bacterial patho-
gens as potential independent causal factors in infant LRIs and
their long-term sequelae. Notably, culture of S. pneumoniae,
M. catarrhalis, orH. influenzae fromNP samples taken at 1month
of age has been linked to increased risk for subsequent diag-
nosis of asthma at 5 years of age (Bisgaard et al., 2007). These
findings have fuelled debate around the use of antibiotics and
vaccine strategies for respiratory illness in children (Penders
et al., 2011; Rollins et al., 2010).
Several studies have investigated airway microbiota in chil-
dren or adults with chronic respiratory illness, including asthmanc.
(Bogaert et al., 2011; Hilty et al., 2010; Vissers et al., 2014); how-
ever, no study has investigated the airway microbiome during
the critical infancy period (0–12 months). In this study, we inves-
tigated the NP microbiome during the first year of life using the
Childhood Asthma Study (CAS), a prospective cohort of 234
children (Kusel et al., 2006, 2007, 2008, 2012), to elucidate the
NP microbiome during respiratory health and illness, its longitu-
dinal dynamics, susceptibility to exogenous factors such as
antibiotics, and association with future asthma.
RESULTS
A total of 1,021 NP microbiome profiles were obtained from 234
infants using 16S rRNA gene deep sequencing (see Supple-
mental Experimental Procedures). These included 487 ‘‘healthy’’
NP samples collected in the absence of respiratory symptoms
and 534 ‘‘infection’’ NP samples collected during episodes of
acute respiratory illness (ARI) during the first year of life. Three
quarters of the infants (n = 177) contributed at least two healthy
NP samples at the age of 2 months, 6 months, and/or
12 months. Eighty percent of the infants (n = 186) contributed
a healthy sample before experiencing their first ARI. The 534
infection NP samples were from 184 infants who had experi-
enced R 1 ARI within the first year of life. NP samples were
analyzed from all (380/381) recorded LRI in this period and a
random selection of 20% (154/782) of recorded episodes of
upper respiratory illness (URI). The characteristics of the infants
are summarized in Table S1.
NP Microbiome Composition
Across all NP samples, > 193 million high-quality 16S rRNA se-
quences were classified into 14,131 operational taxonomic units
(OTUs), of which 1,010 were supported by > 1,000 reads each.
The dominant phyla were Proteobacteria (48%), Firmicutes
(38%), Actinobacteria (13%), Bacteroidetes (1%), and Fusobac-
teria (0.5%) (Figure 1A). The NPmicrobiomeswere dominated by
six genera: Moraxella (31.2%), Streptococcus (15.5%), Coryne-
bacterium (13.5%), Staphylococcus (10.3%), Haemophilus
(9.7%), and Alloiococcus (8.8%; genus Dolosigranulum in
some databases) (Figure 1A). Despite the inclusion of diverse
OTUs of these genera in the reference database, our sequences
were dominated by one OTU per genus (Figure S1), consistent
with culture-based studies reporting NP colonization with the
species Moraxella catarrhalis, Streptococcus pneumoniae,
Staphylococcus aureus, Haemophilus influenzae, and Alloiococ-
cus otitidis. Hierarchical clustering of NP microbiomes based on
relative abundance of the six major genera identified six
microbiome profile groups (MPGs, Figure 1B). Each MPG was
dominated by one of the six genera, although some samples in
the Alloiococcus MPG also had relatively high abundance of
Corynebacterium (Figure 1B).
NP Microbiome Dynamics
Healthy NP samples collected around 2 months of age were
dominated by Staphylococcus (41%) and Corynebacterium
(22%) MPGs, but the frequency of these MPGs declined with
age (11% and 10%, respectively, at 12 months old) (Figure 1C).
In contrast, the prevalence of Alloiococcus and Moraxella
MPGs in healthy samples increased with age (14% and 9%Cell Hat 2 months, 26% and 41% at 12 months, respectively). Anal-
ysis of MPG transitions among consecutive healthy NP
samples from the same individuals (Figures S3A and S3B)
suggested that Staphylococcus carriage was unstable or tran-
sient, particularly where an ARI had occurred in the intervening
period between sampling. Alloiococcus was a stable colonizer,
but less so if an ARI occurred between sampling. Where an ARI
occurred in the intervening period between healthy samples,
the most common transitions were to the Moraxella MPG
from other MPGs or the maintenance of stable colonization
with Moraxella (Figure S3B). Almost all Moraxella-colonized in-
fants experienced subsequent ARI before the next healthy
sample was taken (explored further below). Haemophilus was
very rarely detected in healthy NP microbiomes, while Strepto-
coccus was present in 14% of healthy samples at each sam-
pling time (Figure 1C). Similar age-related patterns were
observed among infection samples, with a decline in Staphylo-
coccus and Corynebacterium MPGs and increase in Moraxella,
Haemophilus, and Streptococcus MPGs in older children (Fig-
ure 1D). Interestingly, males had significantly more Moraxella
in healthy samples (OR 1.3 for log abundance; 95% CI 1.1–
1.5, p = 0.0014, adjusted for age); no other gender effects
were detected.
We next assessed the impact of environmental factors on the
relative abundance of the common NP microbiome genera. We
found no significant effects of delivery mode or breastfeeding
on NP colonization at 2 months of age; the latter was unsurpris-
ing as nearly all infants (90%) were breastfed for at least
2 months. The abundance of Streptococcus in healthy NP sam-
ples was significantly lower among children whose parents re-
ported having furry pets such as dogs or cats in the home (OR
0.84, 95% CI 0.70–1.0, p = 0.046; adjusted for age at NP sam-
pling). No other significant associations were detected for pets.
Children attending day care had significantly higher relative
abundances of Haemophilus and Moraxella and lower relative
abundances of Corynebacterium and Staphylococcus (Fig-
ure 2A) in both healthy and infection samples (note that very
few children had commenced day care by 6 months of age,
hence the impact of day care attendance was assessed at the
12-month time point only). Co-habiting with siblings was also
associated with higher abundances of Haemophilus, Strepto-
coccus, andMoraxella and lower abundance of Staphylococcus
during health and ARI (adjusted for age at sampling, Figure 2B).
Importantly, among healthy samples, antibiotic usage in the four
weeks prior to sampling was associated with higher abundances
of Haemophilus, Streptococcus, andMoraxella and lower abun-
dances of Alloiococcus and Corynebacterium (adjusted for age
at sampling, Figure 2C). The composition of the healthy NP mi-
crobiomewas also affected by the number of prior respiratory in-
fections experienced, with higher abundance of Moraxella and
lower abundances of Alloiococcus or Corynebacterium in sam-
ples following increasing numbers of ARIs (Figure 2E). At the
MPG level, ARIs dominated by Haemophilus increased in
spring-summer, while those dominated by Moraxella peaked in
autumn-winter (Figure 2F). We therefore tested for differences
in relative abundance in autumn-winter and spring-summer,
adjusting for age and number of prior infections; this confirmed
significant seasonal effects on the abundance of Haemophilus
(summer associated) and Moraxella (winter associated) amongost & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Inc. 705
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Figure 1. Bacterial Composition of 1,021 Nasopharyngeal Aspirates Collected from 234 Infants during Periods of Respiratory Health and
Disease
(A) Frequency of the most abundant phyla and genera (comprising 99.9% of reads).
(B) Clustering of samples into microbiome profile groups (MPGs) based on relative abundance of the six most common genera. Colored bars indicate MPGs,
labeled by their dominant genus: Moraxella (red), Corynebacterium (blue), Alloiococcus (green), Staphylococcus (purple), Haemophilus (yellow), and Strepto-
coccus (orange).
(C) Weekly frequencies of MPGs among healthy samples, collected during planned visits at approximately 2, 6, and 12 months of age and following at least
4 weeks without symptoms of acute respiratory infection (ARI).
(D) Weekly frequencies of each MPG among ARI samples.
(E) Odds ratios for association of MPGs with ARI symptoms, adjusted for age, gender, season, number of prior infections, antibiotics intake, mother’s antibiotics
intake, delivery mode, and breastfeeding; with and without adjustment for detection of common viruses (RSV, HRV).
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Figure 2. Impact of Environmental Factors on Relative Abundances of Major Genera of the NP Microbiome
(A–D) Squares, odds ratios; filled squares, healthy samples; empty squares, infection samples; bars, 95% confidence intervals; *p < 0.1, **p < 0.05, ***p < 0.01.
Associations are estimated using logistic regression and adjusted for age: (A) day care attendance (yes versus no, 12-month samples), (B) co-habiting with
siblings, (C) antibiotics intake in the 4 weeks preceding NP sample collection, (D) season (spring-summer versus autumn-winter).
(E) Impact of prior ARI, estimated using proportional odds ordinal logistic regression and categorized as 0, 1, orR 2 ARI.
(F) Seasonal patterns: top, mean maximum and minimum temperatures in study location (Perth); bottom, monthly proportions of samples in each microbiome
profile group (MPG) for infection and healthy samples.
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Table 1. Associations between ARI Symptom Severity and Risk-Associated MPGs
Symptom Group
Comparison Model
Streptococcus, Moraxella, or Haemophilus MPG
RSV HRV (expanded screen)Streptococcus MPG Moraxella MPG Haemophilus MPG
LRI versus URI 1A OR = 2.2 (1.3–3.7), p = 0.0043 2.2 (1.1–4.7),
p = 0.034
–
1B 2.3 (1.2–4.5),
p = 0.011
2.1 (1.1–3.8),
p = 0.017
2.1 (1.0–4.6),
p = 0.056
2.3 (1.1–4.8),
p = 0.033
–
Febrile LRI versus
non-febrile LRI
2A OR = 3.8 (1.0–14), p = 0.047 4.0 (1.6–9.8),
p = 0.0031
0.45 (0.21–0.95),
p = 0.036
2B 4.3 (1.0–18),
p = 0.046
3.8 (0.98–15),
p = 0.053
2.7 (0.53–14),
p = 0.23
4.0 (1.6–10),
p = 0.0031
0.46 (0.21–0.98),
p = 0.043
Wheezy LRI versus
non-wheezy LRI
3A OR = 1.4 (0.60–3.1), p = 0.45 0.94 (0.41–2.1),
p = 0.88
1.2 (0.62–2.2),
p = 0.64
3B 1.1 (0.39–3.0),
p = 0.88
1.8 (0.74–4.1),
p = 0.20
1.0 (0.34–3.2),
p = 0.93
0.95 (0.42–2.2),
p = 0.90
1.1 (0.60–2.2),
p = 0.69
Odds ratio (OR) (95% confidence interval), p value. NP samples taken within a week of antibiotic use were excluded from analysis. The response var-
iable (symptom group comparison) is shown in column 1. Twomodels (A, B) were fit for each comparison, labeled in column 2.Model A included Strep-
tococcus orMoraxella or HaemophilusMPG as a single covariate; Model B included Streptococcus,Moraxella, and HaemophilusMPGs as separate
covariates. Bothmodels also include RSV, HRV, and the potential confounders age, gender, and season. Note: HRVwas not included in the LRI versus
URI comparison, as enhanced sensitivity re-screening for HRV was performed only in LRI samples.ARI samples and a similar but non-significant trend among
healthy NP samples (Figure 2D).
NP Microbial Determinants of ARI Symptoms
The Moraxella, Streptococcus, and Haemophilus MPGs were
significantly more frequent in ARI compared to healthy NP sam-
ples, even after adjusting for a large set of potential confounders
(age, gender, season, number of prior infections, antibiotic
intake, mother’s antibiotic intake, delivery mode, and breast-
feeding) (Figure 1E). The Staphylococcus, Corynebacterium,
and Alloiococcus MPGs were significantly less frequent in ARI
(Figure 1E). The rare genusNeisseriawasmore common in infec-
tion samples, especially LRIs (of 28 NP samples with > 5% rela-
tive abundance of Neisseria, 4 were from URI and 20 were from
LRI, though all were co-colonizedwithStreptococcus). It was not
possible to confirm species from the 16S sequences; however, it
is well known that the respiratory pathogens S. pneumoniae,
H. influenzae, M. catarrhalis, and N. meningitidis are frequently
cultured from respiratory infections in children. We have previ-
ously measured IgG to species-specific surface proteins of
S. pneumoniae and H. influenzae at 12 months of age in
the CAS cohort (Hales et al., 2012). Here we found that
H. influenzae-specific IgG was significantly associated with the
number of prior ARI samples testing positive for either of the
two most common Haemophilus OTUs (Figures S2A–S2C);
similar results were obtained for S. pneumoniae-specific IgG
antibodies and the dominant Streptococcus OTU (Figures
S2D–S2F). Healthy colonization with these genera was not asso-
ciated with species-specific IgG.
A total of 138 children had R 2 ARI samples profiled, and of
these, 97 (70%) hadR 2 different MPGs among their ARIs. There
was a clear temporal trend, with infections occurring closer in
time more likely to be of the same MPG (Figure S3D). Moraxella
and Haemophilus MPGs were particularly stable between
consecutive infections, i.e., following an ARI in which theMorax-
ella or Haemophilus MPG was present, the next ARI was more
likely to share the same MPG type than expected given the708 Cell Host & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Ioverall frequency of these MPGs among infection samples
(Figure S3C).
We further considered the impact of the NP microbiome on
infection severity and interactions with viral pathogens. All sam-
ples analyzed here were previously screened for a panel of vi-
ruses (Kusel et al., 2006). This screen detected viruses in 21%
of healthy samples, 68% of URIs, and 69% of LRIs. The most
common viruses detected were RSV (11% of ARI) and HRV
(40% of ARI) (Figure S4), although subsequent expanded
screening and subtyping of HRV in LRI samples suggests this
is an underestimate (see below). For all virus groups except
adenovirus and coronavirus, virus detection was significantly
positively associatedwith ARI symptoms (i.e., ARI versus healthy
samples, Figure S4). The association between ARI and Strepto-
coccus, Haemophilus, and Moraxella MPGs remained after
adjusting for detection of virus (OR 7.0, p < 1 3 1015 for any
of these MPGs; individual ORs in Figure 1E), indicating both
viruses and bacteria contribute to ARI symptoms. Among the
viruses analyzed, only RSV was significantly more frequent in
LRIs versus URIs (16% versus 8.3%, OR 2.3; Figure S4, Table 1).
The illness-associated MPGs Streptococcus, Haemophilus, and
Moraxella were significantly associated with LRIs versus URIs
(OR > 2), individually and collectively, adjusting for the effect
of RSV (Table 1). As a group, the illness-associated MPGs
increased in frequency from healthy to URI to LRI samples,
regardless of the presence of RSV (Figure S5). Taken together,
these analyses indicate that both viruses and bacteria indepen-
dently contribute to ARI and that bacteria and RSV indepen-
dently increase the risk of infection spread to the lower airways.
In our earlier studies with this cohort, we observed an associ-
ation between LRIs (but not URIs) during infancy and risk for
wheeze at age 5 years; moreover, this association was restricted
to severe LRIs, i.e., those accompanied by fever and/or wheeze
(Holt et al., 2010; Kusel et al., 2007, 2012). Thus we investigated
the association of viruses and bacteria with the presence of fever
and wheeze symptoms during LRI. To enable more accurate
assessment of the role of HRV in this critical sample group, wenc.
Table 2. Association between Microbial Events during Infancy and Chronic Wheeze at Age 5 and 10 Years
Wheeze at 5 Years Wheeze at 10 Years
All children Atopics All children Atopics
Any febrile LRI 2.3 (1.2–4.5), p = 0.016* 2.7 (1.1–7), p = 0.034* 2.2 (0.93–5.2), p = 0.071 2.7 (0.89–8.7), p = 0.083
Any wheezy LRI 1.6 (0.79–3), p = 0.2 1.3 (0.49–3.3), p = 0.61 1.4 (0.58–3.3), p = 0.45 1.6 (0.53–4.8), p = 0.4
Any HRV wheezy LRI 2 (0.93–4.2), p = 0.073 2.5 (0.86–7.2), p = 0.092 2.1 (0.81–5.4), p = 0.11 1.9 (0.55–6.4), p = 0.29
Any HRV-C wheezy LRI 2.4 (0.93–6.1), p = 0.064 7.2 (1.7–35), p = 0.009* 3.5 (1.1–11), p = 0.026* 7.1 (1.6–40), p = 0.014*
Any HRV-A wheezy LRI 1.2 (0.42–3.1), p = 0.74 0.55 (0.11–2.2), p = 0.43 1.4 (0.37–4.7), p = 0.57 0.35 (0.02–2.2), p = 0.34
Any risk bacteria LRI 0.89 (0.45–1.8), p = 0.73 0.96 (0.39–2.4), p = 0.93 2 (0.82–5.2), p = 0.14 1.7 (0.59–5.2), p = 0.34
High-abundance Streptococcus
colonization (%7 weeks)
3.8 (1.3–12), p = 0.017* 4 (0.88–21), p = 0.077 2.7 (0.6–12), p = 0.18 3.9 (0.63–28), p = 0.15
Odds ratio (95% confidence interval), p value; estimated using logistic regression, adjusted for gender andmaternal and paternal history of atopic dis-
ease; estimated separately for all children and those who were atopic by 2 years of age. LRI, lower respiratory illness, further classified according to
microbes and symptoms; any risk bacteria LRI, any LRI with Streptococcus,Moraxella, or HaemophilusMPG. Early Streptococcus colonization was
assessed in the first healthy NP sample, collected by 7 weeks of age and prior to any recorded infection; high abundance was classified as > 20%
Streptococcus reads (based on distribution in Figure 5A).performed an expanded screen for detection and subtyping of
HRV within LRI samples (Supplemental Experimental Proce-
dures). This assay proved more sensitive than the first screen
and detected HRV in 66%of LRI samples (twice that in the earlier
screen), with equal amounts of HRV-A and HRV-C (Figure S4).
During LRI, the presence of any HRV, or HRV-C specifically,
was negatively associated with fever (Table 1). The only viruses
showing positive associations with fever were RSV (Table 1, Fig-
ure 3C, Figure S4) and influenza (8 influenza-positive fever LRI
events only, all with illness-associated MPGs, thus not consid-
ered further). Among LRIs, the illness-associated MPGs were
associated with fever, even after adjusting for RSV, HRV, age,
season, and gender (Table 1). Interestingly, Moraxella MPG
was also significantly positively associated with fever among
RSV-positive LRIs (OR 9.2, 95%CI 1.1–73, p = 0.037; Figure S5),
suggesting a possible interaction between Moraxella and RSV
whereby their co-presence further enhances risk of fever. Over-
all, only 10 febrile LRIs (9.5%) could not be explained by the
presence of RSV or illness-associated MPGs. Across the cohort,
the presence of wheeze during LRI was not significantly associ-
ated with any viral or bacterial groups (Table 1), including HRV or
HRV-C specifically. Of all ARIs analyzed, there were 61 with
concomitant otitis media (OM) affecting 47 infants; however,
ARIs with accompanying OM had similar NPmicrobiome profiles
to those of LRIs with no OM diagnosis (Table S2).
Impact of ARI on Later Chronic Wheeze
Wenext investigated associations between LRI in the first year of
life and subsequent expression of chronic wheeze at age 5 or 10
years. Positive associations were found for two discrete classes
of LRI. First, febrile LRI was significantly positively associated
with later chronic wheeze and among children who were atopic
by 2 years of age (Table 2). Furthermore, timing of first febrile
LRI appeared to be important, with earlier febrile LRI occurring
among children who had chronic wheeze at 5 years (p =
0.0095, Figure 3A). Second, HRV-C LRI accompanied by
wheezing symptoms showed a positive association with later
chronic wheeze among all children and particularly strongly so
for those who were atopic by 2 years (OR 7, Table 2), but not
among non-atopics (OR 1, p = 0.95; Table S3). As we found noCell Hassociation between HRV-C and wheeze during LRI across the
whole cohort (OR 1.2, 95% CI 0.63–2.2, p = 0.61; adjusting for
illness-associated MPGs, RSV, age, season, and gender), we
re-examined the association in those who developed atopy by
age 2. Among this group of children (n = 65), the presence of
HRV-C was significantly positively associated with increased
risk of wheeze during LRI (OR 2.7, 95% CI 1.1–7, p = 0.035;
adjusting for illness-associated MPGs, RSV, age, season, and
gender).
Since febrile LRI and HRV-Cwheezy LRI were both associated
with later chronic wheeze (Table 2), and RSV was associated
with febrile LRI (Table 1), we examined the interaction between
RSV, HRV-C, LRI symptom severity, and chronic wheeze at
age 5. Febrile LRI and wheezy HRV-C LRI in the first year of
life appeared to exert independent effects on later chronic
wheeze, since only a minority of HRV-C wheezy infections
were also febrile (Figure 3C). Further, at the level of individual
children, the frequency of chronic wheeze at 5 years was
elevated among those with either one of febrile LRI (36%) or
wheezy HRV-C LRI (30%) but was greatest among children
who experienced both (58%, Figure 3D).
Impact of NP Colonization on ARI
Whereas Streptococcus,Haemophilus, orMoraxellaMPGswere
detected in healthy NP samples, subsequent infections tended
to belong to the same MPG (Figure 4A). Critically, we investi-
gated whether healthy colonization in early infancy was associ-
ated with subsequent episodes of ARI. Since prior infections
also affect the healthy NP microbiome (Figure 2E), we restricted
these analyses to healthy samples collected at 5–9 weeks of age
and prior to each infant’s first reported ARI (n = 160). Using Cox
proportional hazards models, infants whose earliest healthy NP
sample was of the Moraxella or Streptococcus MPG tended to
experience ARI at a younger age than those with other MPGs
(Figure 4B; note that Haemophilus MPGs were extremely rare
in early healthy samples). When examining URIs and LRIs sepa-
rately, we found that earlyMoraxella colonization was associated
with earlier first URI, whereas early Streptococcus colonization
was strongly associated with earlier first LRI (Figures 4C and
4D). Since our data suggested that Alloiococcus and Moraxellaost & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Inc. 709
C D
A B Figure 3. Symptoms of Lower Respiratory
Illness during the First Year of Life Are Asso-
ciatedwith Viruses Present during the Infec-
tion and Predict Chronic Wheeze at 5 Years
of Age
(A and B) Kaplan-Meier survival curves for age
(days) at (A) first febrile LRI and (B) first HRV-C
wheezy LRI, stratified by chronic wheeze status at
5 years. p values shown were estimated using Cox
proportional hazards models, adjusted for gender
and maternal and paternal history of atopic dis-
ease. Shaded areas indicate 95% confidence
intervals.
(C) Frequencies of fever and wheeze symptoms
during LRI, in which HRV-C and/or RSV were de-
tected. Total numbers are: HRV-C only, n = 79;
HRV-C and RSV, n = 14; RSV only, n = 22.
(D) Cross-tabulation of individuals according to
their experience of LRI during infancy; percent-
ages in brackets indicate frequency of chronic
wheeze at 5 years.were key stable colonizers of the NPmicrobiome, we also exam-
ined whether Alloiococcus-colonized infants differed from
Moraxella-colonized infants (defined as those with R 1 healthy
sample of Moraxella MPG and none with Alloiococcus MPG,
and vice versa). These groups did not differ in terms of overall
numbers of ARI, LRI, or later wheezing phenotypes. However,
compared to either Moraxella-colonized infants or those not in
either group, Alloiococcus-colonized infants had fewer RSV in-
fections, especially RSV LRIs (OR 0.27, Table S4).
Early NP Colonization Impacts Later Chronic Wheeze
We next assessed the association between early pre-ARI
asymptomatic NP colonization and current wheeze at 5 and 10
years of age, stratified by atopic sensitization by 2 years of age
(Supplemental Experimental Procedures). This analysis was
restricted to the 160 infants (70%) who had an asymptomatic
NP sample taken prior to their first ARI (and % 9 weeks of
age). Haemophilus MPG was not detected in pre-ARI healthy
samples, and Moraxella MPG showed no evidence of associa-
tion with future wheeze. The Streptococcus MPG showed a
weak association; however, the relative abundance of Strepto-
coccus in these samples was highly skewed, so we divided
samples into those with high (> 20%) or low (% 20%) relative
abundance of Streptococcus reads (Figure 5A). High Strepto-
coccus abundance in the first pre-ARI healthy NP sample was
more frequent in infants who later displayed wheeze at 5 years,
and this association was stronger when restricting the analysis
to earlier NP samples (Figure 5B, Table 2). The same trend was
evident for wheeze at 10 years of age, despite reduced sample
size due to loss to follow-up (Table 2). Early Streptococcus colo-
nization was associated with younger age at first LRI (Figure 4D),
but not with presence of Streptococcus in the first LRI or with
detection of S. pneumoniae antibodies at 12 months of age.
No statistically significant associations were observed for future
chronic wheeze when aggregating the 7-week healthy Strepto-
coccus, Haemophilus, andMoraxellaMPGs into a single predic-
tor (with or without atopy by 2 years). Overall, infants who were
atopic by age 2 and developed chronic wheeze at age 5 were710 Cell Host & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Itwice as likely to have had early Streptococcus colonization,
febrile LRI, and/or HRV-C wheezy LRI in the first year of life,
compared to those that did not develop chronic wheeze
(Figure 5C).
DISCUSSION
NP Microbiome Composition and Dynamics
Our data provide a detailed prospective characterization of bac-
terial communities within the human NP microbiome during the
first year of life. The NPmicrobiomewas qualitatively simple (Fig-
ure 1), dominated by six common genera:Haemophilus,Strepto-
coccus,Moraxella (each more common in ARI), Staphylococcus,
Alloiococcus, and Corynebacterium (more common in healthy
samples). This is consistent with previous studies of NP micro-
biome composition in children aged 12–14 months (Biesbroek
et al., 2014; Bogaert et al., 2011) and adults (Hilty et al., 2010),
although intra- and inter-sample diversity was greater in these
older groups, likely due in part to extreme seasonal variation in
those study locations. In contrast, our study site in Perth,
Australia has a very moderate climate, and we detected only
limited seasonal effects (Figure 2D) that were readily adjusted
for, enabling us to assess the dynamics of the NP microbiome
at different stages of infancy and to examine its association
with other factors.
We found that early NP colonization typically involved Staph-
ylococcus or Corynebacterium, which was later replaced by
Moraxella or Alloiococcus. Staphylococcus was the dominant
colonizing bacteria in the early healthy NP microbiomes, but its
presence declined rapidly with age (Figure 1). S. aureus is a com-
mon cause of neonatal sepsis, and high rates of S. aureus nasal
colonization in the first months of life have been reported (Bis-
gaard et al., 2007, 2010). Few studies have examined longitudi-
nal colonization; however, a recent study in African children
reported S. aureus colonization in 42% of infants at 1 month
and 12% at 12 months of age, a trend that was mirrored in
maternal colonization rates (Schaumburg et al., 2014) and is
strikingly similar to the patterns we observed (41% at 2 months,nc.
A B
C D
Figure 4. Impact of Early Colonization on Age at First Respiratory Infection
(A) Microbiome profile group (MPG) transitions between healthy samples (T1) and the next sequenced infection (T2). Cell numbers indicate the number of times
the respective transition from T1 to T2 was observed in the dataset; cells are colored to indicate the row proportions as per legend.
(B–D) Kaplan-Meier survival curves for age (days) of first (B) acute respiratory illness (ARI), (C) upper respiratory illness (URI), and (D) lower respiratory illness
(LRI), stratified according to the MPG of the first healthy sample (collected by 9 weeks of age and prior to any infection, n = 160). Cox proportional hazards
models were adjusted for age, gender, season, virus status in the early healthy sample, and virus status at the first event. Shaded areas indicate 95% confidence
intervals.11% at 12 months). Staphylococcus and Corynebacterium are
both common components of the human skin microbiome, and
in our data they showed a comparable temporal pattern, with
high rates in the early NP microbiome declining with age (Fig-
ure 1). We speculate that infants tend to be colonized initially
with skin-dwelling bacteria (acquired from parents and others),
which is replaced over time by stable colonization withMoraxella
or Alloiococcus and punctuated by transient acquisition of
Streptococcus or Haemophilus that is frequently accompanied
by ARI symptoms. Our data further suggest the transition to
Moraxella is associated with exposure to other children (in the
home or at day care) and episodes of ARI, and that colonization
with Moraxella, Streptococcus, and Haemophilus are selected
for by antibiotic exposure (Figure 2).
Moraxella was the most common genus in our study popula-
tion, dominating 21% of all healthy NP microbiomes and
38% of infection samples. Moraxella was represented in our
sequence data by a single OTU matching that of M. catarrhalis,
a human-restricted, unencapsulated, Gram-negative bacterium
previously associated with both commensal NP colonization
and pathogenicity in the respiratory tract and inner ear (de
Vries et al., 2009). Increased rates of NP colonization withCell HM. catarrhalis have been reported in children following pneumo-
coccal vaccination (Revai et al., 2006); however, the samples in
our study predate introduction of this vaccine. In our cohort
the presence of Moraxella increased with age, and Moraxella
was a particularly stable component of the NP microbiome dur-
ing both health and disease (Figure S3). These findings are
consistent with Moraxella’s known ability to form biofilms (de
Vries et al., 2009), which offer protection from antibiotics and
promote co-colonization with other common bacteria such as
S. pneumoniae and H. influenzae (Verhaegh et al., 2011).Morax-
ella was more abundant during the cooler months (Figure 2), a
seasonal trend consistent with recent reports that cold shock
at 26C stimulates growth, colonization, and expression of viru-
lence-associated traits in M. cattarhalis (Spaniol et al., 2011).
These data are consistent with a Dutch culture-based study of
M. catarrhalis carriage in young children (Verhaegh et al.,
2011), which found increasing prevalence of M. catarrhalis dur-
ing the first year of life, with a strong seasonal effect (also
observed in a Swedish cohort [Gisselsson-Sole´n et al., 2014])
and a significant positive association with day care attendance
and siblings. However, these studies did not examine the
stability of Moraxella colonization within individuals over time.ost & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Inc. 711
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A B Figure 5. Predictors of Chronic Wheeze at
Age 5
(A) Streptococcus abundance among healthy
samples collected by 9 weeks of age, broken
down by microbiome profile group (MPG).
(B) Adjusted odds ratio (OR, squares) and 95%
confidence intervals (bars) for association be-
tween chronic wheeze at age 5 and high (> 20%)
abundance ofStreptococcus in the first healthy NP
sample; p values and sample sizes (n) are indi-
cated; individuals who experienced an infection
prior to first healthy NP sample collection were
excluded.
(C) Distribution of microbial events during infancy
that were identified as risk factors for chronic
wheeze at 5 years of age, stratified according
to atopic status by age 2. fLRI, febrile LRI;
wHRV-C, HRV-C LRI accompanied by wheeze;
Strep, > 20% Streptococcus abundance in
healthy NP sample taken in by 9 weeks old and
prior to any ARI; unknown Strep, no such NP
sample available (mainly due to ARI before
9 weeks of age); unknown LRI, incomplete viral/
symptom profiling for LRI. Size of pie chart is
proportional to the number of infants in each
condition.Importantly, our data show that the presence of Moraxella con-
tributes to severity of RSV respiratory infections in infants (Fig-
ure S5, Table S3), which may be mechanistically related to
RSV-Moraxella interactions reported in OM pathogenesis
(Brockson et al., 2012).
Alloiococcuswas a common and stable component of healthy
NP samples and demonstrated enhanced stability in healthy NP
microbiomes (Figure S3). Alloiococcus is a Gram-positive bacte-
rium with one named species, A. otitidis, frequently detected in
the ear canals of children with OM. Little is known about its
mechanisms of colonization; however, the stable colonization
patterns we observed may reflect a propensity to form stable
biofilms, similar to Moraxella. The Alloiococcus MPG included
some samples with high abundances of both Alloiococcus
and Corynebacterium, indicating compatibility between these
bacteria somewhat reminiscent of that between the Moraxella
biofilm and Streptococcus or Haemophilus. Whether Alloiococ-
cus is involved in OM pathology or is merely a healthy compo-
nent of the microbiome is controversial (Tano et al., 2008); in
our data, Alloiococcus was not associated with ARI or OM (Fig-
ure 1, Table S2).712 Cell Host & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Inc.Haemophilus was almost exclusively
associated with ARI symptoms and was
often found in consecutive infections,
suggesting it can persist in the naso-
pharynx for some time (Figure 1, Table
1, Figure S3). Our analyses also suggest
Haemophilus is highly transmissible
between children and selected for by
antibiotic exposure (Figure 2). Although
our data include multiple Haemophilus
OTUs, these epidemiological patterns
are consistent with the human-adaptedpathogen H. influenzae, which was supported by antibody data
(Figure S2).
Role of the NP Microbiome in Asthma Development
We have previously reported that within the CAS cohort, the fre-
quency during the first year of life of severe (wheezy and/or
febrile) LRI was positively associated with subsequent risk for
persistent wheeze at 5 and 10 years of age (Holt et al., 2010; Ku-
sel et al., 2007, 2008), and similar findings have been reported in
the U.S.-based COAST cohort (Gern, 2009). In both these study
populations, the susceptible subgroup of children were those
who developed early allergic sensitization (Gern, 2009; Holt
et al., 2010, 2014; Jackson et al., 2008; Kusel et al., 2007,
2012; Oddy et al., 2002), and a variety of evidence suggests
that the underlying mechanism involves synergistic interactions
between atopic and anti-viral inflammatory pathways triggered
within the infected airway mucosa (Holt and Sly, 2012). Of
note, ARIs that remain restricted to the upper respiratory tract,
and infections resulting in only mild LRI without wheezing or
febrile symptoms, are relatively benign with respect to asthma
risk in this cohort (Holt et al., 2010; Kusel et al., 2007, 2012)
(Table S3). Hence cofactors that can enhance the spread and
ensuing severity of viral-initiated ARI are potentially central to
asthma pathogenesis.
Here we found that two specific classes of LRI, namely febrile
LRI and HRV-C-positive wheezy LRI, were independent risk fac-
tors for later chronic wheeze, especially among atopics (Table 2,
Figure 3). Febrile LRI was common, occurring in one-third of all
children and half of atopic chronic wheezers at age 5 (Figure 3
and Figure 5). Notably, the presence of illness-associated bacte-
ria within the NP microbiome at the time of ARI increased both
the risk for progression to the lower respiratory tract and the
development of fever (Table 1). These mechanisms likely include
myriad bacterial-viral interactions (recently reviewed by Vissers
et al., 2014). In contrast, neither specific virus groups nor bacte-
rial MPGs were associated with wheezy versus non-wheezy LRI
within the overall population (Table 1), and the impact of wheezy
LRI on later chronic wheeze was limited to LRI with HRV-C
(Table 2), which occurred in just 11% of children. Re-examina-
tion of wheeze symptoms during LRI stratified by atopic status
identified a positive association between HRV-C and wheeze
during LRI among those children who later became sensitized
(by 2 years of age), consistent with observations that HRV-C
can induce wheeze in high-risk individuals (Lee et al., 2012).
However, the presence of wheezy LRI alone, without further
stratification by HRV-C detection and later atopic status, was
not a significant predictor of later chronic wheeze, while febrile
LRI per se was a significant predictor of chronic wheeze at 5
and 10 years, both among atopics and across the whole cohort
(Figure 5, Table 2).
Early asymptomatic Streptococcus colonization at2 months
of age, which occurred in 14% of children tested at that time,
was significantly associated with chronic wheeze at 5 years of
age (Figure 5, Table 2). Early Streptococcus colonization was
not associated with incidence of infections with Streptococcus
MPG, nor with detection of S. pneumoniae-specific antibodies
at 12 months, suggesting that the mechanism is independent
of innate immune response to Streptococcus. Rather, early
Streptococcus colonization was associated with younger age
of first LRI, and the level of subsequent asthma risk appears
inversely related to age at initial Streptococcus colonization (Fig-
ure 4 and Figure 5). Collectively, these observations suggest that
developing airway tissues may be maximally susceptible to the
long-term effects of Streptococcus-mediated or LRI-mediated
damage during the early postnatal period, when lung growth
rates are most rapid.
To our knowledge, the only other study reporting the impact of
early life NP colonization on wheeze/asthma at pre-school age is
the 2007 report on the Copenhagen Prospective Study on
Asthma in Childhood (n = 321, children born to mothers with
asthma), in which a higher rate of wheeze at 5 years of age
was detected among children colonized with S. pneumoniae,
M. catarrhalis, and/or H. influenzae at 1 month post-birth (in cul-
ture-confirmed colonized, asthma prevalence was 33%, not
colonized, 10%, OR 4.57) (Bisgaard et al., 2007). In that study,
associations were not reported individually for the three species
and colonization wasmeasured as positive or negative bymicro-
biological culture. In our cohort, wheeze at 5 years was not asso-
ciated with early colonization with Haemophilus or Moraxella;
however, Haemophilus was very rare in healthy NP samples,Cell HandMoraxella colonization was established later during infancy,
whichmay be related to the warmer climate in Perth; these asso-
ciations may differ in populations where asymptomatic carriage
of these organisms is higher.Conclusions and Implications
These findings collectively suggest that bacterial pathogens pre-
sent in the NP microbiome at the time of upper respiratory viral
infections during infancy are significant determinants of risk for
the spread of infection to the lower airways and for the resultant
expression of inflammatory symptoms marked by fever, and
further, they may contribute directly and indirectly to the ensuing
risk for development of persistent asthma, which itself is linked to
these prior infectious episodes. Prevention of RSV or HRV infec-
tions in high-risk children, using immunoprophylaxis or vaccines,
has been proposed as a mechanism for preventing the develop-
ment and/or exacerbation of childhood asthma (Gern, 2009; Wu
andHartert, 2011). Our data suggest that in the absence of effec-
tive anti-viral therapies, targeting pathogenic bacteria present
within the NP microbiome in this age group could represent an
alternative approach toward the same goal. The pneumococcal
vaccine, currently recommended from 2 months of age, could
play a role; however, the niche created by eliminating vaccine-
targeted S. pneumoniae serotypes can be readily filled by other
serotypes and other bacteria such as H. influenzae and
M. catarrhalis (Biesbroek et al., 2014; Revai et al., 2006). Manip-
ulation of the microbiome by antibiotics may appear attractive;
however, the association between antibiotic use in early child-
hood and subsequent asthma is controversial. In the CAS cohort
(Kusel et al., 2008) and others (Semic-Jusufagic et al., 2014), this
association has been proposed to arise through confounding
and reverse causation, whereby genetic or clinical factors in-
crease the likelihood of both antibiotic prescription (e.g., via ge-
netic susceptibility to viral infection [Semic-Jusufagic et al.,
2014]) and asthma development; others have proposed that
antibiotic-induced disruption of the gut microbiota could explain
the link (Arrieta and Finlay, 2014). Our analyses provide a poten-
tial causal pathway linking antibiotics to later asthma, whereby
antibiotic use in infants selects for illness-associated bacteria
in the NP microbiome, leading to increased risk of febrile LRI
and later asthma development. Genetic analysis of the infants
in our cohort could potentially help to unravel this in the future.
Importantly, further studies are required to prospectively assess
the impact of antibiotic use on NP bacterial colonization during
health and infection, and the subsequent development of ARI,
atopy, and wheeze.EXPERIMENTAL PROCEDURES
Study Design
This study is an extension of the Childhood Asthma Study (CAS), a birth cohort
of 234 infants at high risk of atopy as previously described (Kusel et al., 2007,
2008). Briefly, healthy NP aspirates (NPAs) were collected from subjects at
planned visits at 2, 6, and 12 months of age. NPAs were also collected within
48 hr from the onset of an ARI; these were classified as either lower respiratory
infection (LRI, if wheeze or rattly chest detected) or upper respiratory infection
(URI, otherwise). NPAs were divided into four aliquots and stored at 80C.
One aliquot was used for bacterial 16S rRNA amplicon sequencing via Illumina
MiSeq and another to screen for viruses including RSV, HRV, and other
picornaviruses, influenza, parainfluenza, coronavirus, adenovirus, and humanost & Microbe 17, 704–715, May 13, 2015 ª2015 Elsevier Inc. 713
metapneumovirus (hMPV). For LRI, a third aliquot was used in an expanded
screen for detection and subtyping of HRV. Study ethics were approved by
the ethics committees of King Edward Memorial and Princess Margaret Hos-
pitals inWestern Australia. Fully informed parental consent was obtained for all
subjects. Details of sample and data collection, viral screening, DNA extrac-
tion, and sequencing are in Supplemental Experimental Procedures.
16S rRNA Sequence Analysis
Paired end reads were merged using Flash v1.2.7 (Magoc and Salzberg, 2011)
with read length 151 base pairs (bp) and expected fragment length 253 bp.
Merged sequences were quality filtered as follows:% 3 low-quality bp (Phred
score < 3) allowed before trimming,R 189 consecutive high-quality bp with no
uncalled bases (Ns) (Bokulich et al., 2013). Thirty-threemillion sequences were
filtered out (13%), leaving 219 million for analysis. These were assigned to
OTUs using the closed reference method in QIIME v1.8 (Caporaso et al.,
2010) with the Greengenes 99% OTU reference set, version 13_5 (McDonald
et al., 2012) (which consists of > 200,000 representative sequences obtained
from clustering all sequences from the Greengenes reference database at
99% sequence similarity). Briefly, this method uses UCLUST (Edgar, 2010)
to search each sequence against the reference set and assigns it to an
OTU based on the best hit atR 99%sequence identity. Sequences notmatch-
ing the reference database (3%) were excluded from analysis; these
sequences could be chimeras, sequencing errors, or novel sequences that
are not well characterized in the database. This left > 200,000 taxonomy-
assigned sequences on average for each NPA (interquartile range: 108,000–
255,000; eight samples with < 1,000 reads). Compared to NPAs, negative
control samples (see Supplemental Experimental Procedures) had clearly
lower total reads (interquartile range: 1,044–2,346) with a different community
structure (Figure S6).
Clustering into MPGs
For each NPA, the relative abundance of each OTU was calculated. Most
analyses were summarized at genus level, whereby all OTUs assigned to the
same genus were collapsed into a single group for reporting. Samples were
assigned to microbiome profile groups (MPGs) based on hierarchical clus-
tering of the relative abundances of the six most common genera (distance
metric: 1-Pearson’s correlation; clusteringmethod: Ward’s minimum variance,
implemented inRhclust). Previousmicrobiome studies have reported clinically
or environmentally meaningful associations with community profiles or types
(e.g., enterotypes) identified using similar clustering approaches (Ravel
et al., 2011; Zhou et al., 2014).
Statistical Methods
All statistical analyses were performed using R. ORs were estimated using
generalized estimating equations (GEE) logistic regression with unstructured
correlation and robust standard errors, to take into account multiple samples
from the same subject. Survival analyses were done using Cox proportional
hazards models. Potential confounders were adjusted for by including them
in the regression models. Full details of each analysis and variable definitions
are given in the Supplemental Experimental Procedures.
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